Thoracic Neoplasms  >>  Conmana (icotinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Conmana (icotinib) / Betta Pharma
MINT, NCT01514877: Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Completed
2
20
RoW
Icotinib
Zhejiang Cancer Hospital
Lung Cancer, Metastatic Cancer
07/14
07/14
NCT01516983: Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation

Checkmark CMSTO 2014
Nov 2014 - Nov 2014: CMSTO 2014
Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
1/2
15
RoW
icotinib, BPI-2009, Conmana, Whole brain radiotherapy, RT, XRT, Radiotherapy, WBRT
Betta Pharmaceuticals Co., Ltd.
Non-small Cell Lung Cancer, Brain Metastases
06/13
12/13

Download Options